U.S. FDA Approves Betaseron(R) (Interferon beta-1b) for Use After the First Event Suggestive of Multiple Sclerosis
Early Treatment With Betaseron Significantly Delayed the Time ... more »
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Multiple Sclerosis Info
Favorite Links
This Month
Month Archive
|
Thursday, December 13
Early Interferon Beta-1b Treatment Thwarts MS Progression
by
All About MS
on Thu 13 Dec 2007 09:24 AM CST
Wednesday, November 28
New natural history of interferon-beta-treated RRMS
by
All About MS
on Wed 28 Nov 2007 12:00 AM CST
New natural history of interferon-beta-treated relapsing multiple sclerosis. Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy. To investigate the impact ... more » Monday, November 26
Avonex may cause Liver Damage
by
All About MS
on Mon 26 Nov 2007 12:00 AM CST
Avonex may cause Liver Damage Biogen and the FDA warned doctors today that the multiple sclerosis drug Avonex (interferon beta-1a) may cause liver damage, ... more » Wednesday, January 4
Avonex (Interferon beta-1a) versus Rebif and Betaseron
by
All About MS
on Wed 04 Jan 2006 12:00 AM CST
Avonex (Interferon beta-1a)Avonex (Interferon beta-1a) is a genetically modified beta interferon produced in mammalian cells. Along with Rebif (Interferon beta-1a), Avonex (approved 1996 U.S FDA) is one ... more » |
|||||||||||||||||||||||||||||||||||||||||||||||||||